Nonclinical services for development of interventional agents for infectious diseases
Ended Awarded Last action
- Contract number
- 75N93024F00005
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $452,091
Award facts
- Contract value 100% obligated
- $452,091.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $452,091 |
About this award
This federal contract award, valued at $452,091.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the non-profit research organization SRI International. The contract is for nonclinical services to support the development of interventional agents for infectious diseases. The award was made under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle titled "Nonclinical Services for Development of Interventional Agents". SRI International, headquartered in Menlo Park, California, has a robust history of providing advanced scientific and technical services to various federal agencies, including the Department of Defense, NASA, and the National Institutes of Health. The contract does not have a set-aside designation, reflecting SRI International's status as a large, established research organization. This award leverages SRI International's specialized technical capabilities across multiple scientific and engineering domains to rapidly develop cutting-edge technologies for addressing complex national challenges in the infectious disease space.
Quick answers
Who was awarded contract 75N93024F00005?
75N93024F00005 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 15, 2024.
How much is contract 75N93024F00005 worth?
The government has obligated $452,091 on 75N93024F00005.
Is contract 75N93024F00005 an order under another contract?
Yes. 75N93024F00005 is a delivery order under 75N93018D00001, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93024F00005 competed?
The extent of competition for 75N93024F00005 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award